CareDx, Inc. CDNA
63.68
2.31
3.76%
as of 25 Sep
- Market cap
- $3.2B
- P/E
- 29.6×
Follow CDNA
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
24.11% | (6.27%) | (2.36%) | 29.49% | |
| 15.50% | (4.72%) | (1.82%) | 22.72% | ||
ROIC |
31.88% | (15.28%) | (8.02%) | 130.06% | |
Return on Tangible Assets |
30.36% | (10.66%) | (3.67%) | 30.64% | |
Average Days of Receivables |
48.78 | 40.97 | 39.42 | 27.39 | |
Free Cash Flow per Share |
0.68 | 0.65 | 1.27 | 1.65 | |
Free Cash Flow |
35.52 | 34.55 | 64.85 | 84.71 | |
Capital Expenditures |
(7.03) | (7.48) | (8.10) | (8.95) | |
Piotroski F-Score |
5.00 | 4.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
8.42% | 8.75% | 14.57% | 11.72% | |
Accounts Receivable Turnover |
6.25 | 7.08 | 7.11 | 9.01 | |
Accounts Payable Turnover |
13.00 | 13.95 | 14.99 | 13.92 | |
Inventory Turnover |
4.87 | 5.33 | 5.21 | 7.72 | |
Average Days of Payables |
36.52 | 29.58 | 25.76 | 25.71 | |
Days of Inventory on Hand |
89.20 | 79.09 | 75.03 | 18.91 | |
Tax Rate |
0.00 | 0.01 | 0.02 | (0.04) | |
Research and Development Expense of Revenue |
19.20% | 18.81% | 18.00% | 17.43% | |
Selling, General and Administrative Expense of Revenue |
57.06% | 55.35% | 54.58% | 54.07% | |
Share Based Compensation of Revenue |
12.09% | 9.18% | 8.66% | 8.07% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.60 | (1.97) | (8.90) | 0.84 | |
Depreciation/Fixed assets |
0.75 | 0.66 | 0.67 | 0.82 | |
Capex/Depreciation |
(0.31) | (0.35) | (0.37) | (0.41) | |
Revenue per Share |
6.82 | 7.13 | 8.07 | 8.90 | |
Operating CF per Share |
0.81 | 0.79 | 1.43 | 1.82 | |
Capex per Share |
(0.13) | (0.14) | (0.16) | (0.17) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
19.68% | (5.62%) | (1.98%) | 24.23% |
Columns are period end dates